0000874015-16-000132.txt : 20160706 0000874015-16-000132.hdr.sgml : 20160706 20160706184154 ACCESSION NUMBER: 0000874015-16-000132 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160701 FILED AS OF DATE: 20160706 DATE AS OF CHANGE: 20160706 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BERTHELSEN SPENCER R CENTRAL INDEX KEY: 0001181548 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 161755089 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2016-07-01 0000874015 IONIS PHARMACEUTICALS INC IONS 0001181548 BERTHELSEN SPENCER R C/O IONIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010 1 0 0 0 Common Stock 2016-07-01 2016-07-01 4 M 0 469 0 A 74812 D Common Stock 2016-07-01 2016-07-01 4 M 0 667 0 A 75479 D Common Stock 2016-07-01 2016-07-01 4 M 0 667 0 A 76146 D Common Stock 2016-07-02 2016-07-02 4 M 0 312 0 A 76458 D Common Stock 70 I by Daughter Restricted Stock Units 2016-07-01 2016-07-01 4 M 0 1803 0 D Common Stock 1803 3801 D Restricted Stock Units 2016-07-02 2016-07-02 4 M 0 312 0 D Common Stock 312 0 D Restricted Stock Units 2016-07-01 2016-07-01 4 A 0 2667 0 A Common Stock 2667 2667 D Director Stock Option (right to buy) 24.42 2016-07-01 2016-07-01 4 A 0 16000 0 A 2017-07-01 2026-06-30 Common Stock 16000 16000 D Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on July 1, 2013. Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on July 1, 2014. Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on July 1, 2015. Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on July 2, 2012. The reporting person disclaims beneficial ownership of all securities held by his daughter, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. Restricted Stock Units vest in equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. Grant of July 1, 2016 to reporting person of Restricted Stock Unit Award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on July 1, 2017. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 1, 2020. The RSU is vested as to 0 shares on July 1, 2016. Grant of July 1, 2016 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, the first installment vesting on July 1, 2017. The option shall be fully vested and exercisable on July 1, 2020. The option is exercisable as to 0 shares on July 1, 2016. /s/B. Lynne Parshall, attorney-in-fact 2016-07-06